Related Experiment Videos
Response to correspondence: "Interferon alpha might be an alternative therapeutic choice for refractory
Frédéric London1, Thierry Duprez2, Vincent van Pesch3
1Department of Neurology, Cliniques Universitaires St-Luc, Université catholique de Louvain (UCLouvain), 10 avenue Hippocrate, Brussels 1200, Belgium; Department of Neurology, CHU UCLouvain Namur, Université catholique de Louvain (UCLouvain), 1 avenue G. Thérasse, Yvoir 5530, Belgium.
Multiple Sclerosis and Related Disorders
|March 20, 2019
Abstract
No abstract available in PubMed .